COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country

Posted by Written by Reading Time: 13 minutes

(This article will be updated continuously. It was originally published on January 28, 2020. It was last updated on March 2, 2021)

Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.

Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ASEAN and Asia updated with the latest relevant regional news.

For specific updates concerning China and related business advisory, please click here.

ASEAN coronavirus updates (Live updates by country)

Brunei

Brunei has joined the global Covax scheme and is expecting to have the COVID-19 vaccine in Q1 2021, having sourced enough supplies to cover 50% of the population. Discussions are on-going with other suppliers.   

  • Brunei recorded one new case on February 17, taking the total to 185.
  • One new case reported on February 12, taking the total to 184.
  • Brunei reported one new case on February 11, bringing the total to 183.
  • The country reported one new case on February 8, bringing the total to 182.

Cambodia

Cambodia is expected to import vaccines from both China and Russia. China’s vaccines are still undergoing clinical trials while Russia has already commenced production. Australia has offered financial support to aid vaccine coverage in several southeast Asia countries including Cambodia.  

  • Cambodia reported 15 new cases on March 1, bringing the total to 820.
  • Cambodia reported 38 new cases on February 28, taking the total to 805.
  • The country reported 28 new cases on February 27, bringing the total to 767.
  • Cambodia saw 44 new cases on February 26, taking the total to 741.

Indonesia

Indonesia has commenced vaccinations with just over nine million doses being given to front line workers from last month. China’s Sinovac is in discussions with Indonesia to provide supplies, however, the Government faces difficulties with a large population of 268 million and price sensitivity at Sinovac’s estimated costs at 200,000 rupiah (US$20) a dose. Indonesia’s Health Ministry’s Disease Control and Prevention Director-General Achmad Yurianto said that vaccinations would only be provided to citizens aged 18-59. The vaccine has also been required to pass halal certification prior to use and it is uncertain how the country can source enough vaccines to reach a sizeable part of its population.  Australia has stated it will also provide financial support to solve these issues.  

  • Indonesia reported 6,680 new cases and 159 deaths on March 1, bringing the totals to 1,341,314 cases and 36,325 deaths.
  • Indonesia recorded 5,560 new cases and 185 deaths on February 28, taking the tallies to 1,334,634 cases and 36,166 deaths.
  • Indonesia reported 6,208 new cases and 195 deaths on February 27, bringing the totals to 1,329,074 cases and 35,981 deaths.

Laos

Laos has been trialing the Russian Sputnik V vaccine and is also in discussions with China about acquiring supplies.  

  • The country saw one new case on February 3, taking the total to 45.
  • Laos recorded three new cases on January 25, taking the total to 44.
  • Laos saw two new cases on December 7, bringing the total to 41.
  • Laos saw 14 new cases on November 25, taking the total to 39.

Malaysia

Malaysia is to provide vaccines free of charge to its nationals, but foreigners will need to pay for the treatment, according to the Malaysian Minister of Health, Tan Sri Muhyiddin Yassin, who has signed a deal with Pfizer for 12.8 million doses. These will be administered in two stages of 6.4 million people each, with the program to commence in Q1 2021. The country aims to inoculate between 80-100% of its citizens. 

  • Malaysia reported 1,828 new cases and five deaths on March 1, taking the totals to 302,580 cases and 1,135 deaths.
  • Malaysia recorded 2,437 new cases and nine deaths on February 28, bringing the totals to 300,752 cases and 1,130 deaths.
  • Malaysia reported 2,364 new cases and 10 deaths on February 27, taking the tallies to 298,315 cases and 1,121 deaths.

Myanmar

Myanmar is seeking assistance from the Gavi and Covax programs to acquire vaccines, while Australia is also providing financial relief. At present, the Government aims to treat 20 percent of the ‘most at risk’ in the country with vaccines. The Government is struggling with finances and logistics and is also under US sanctions, while cases are surging. The Government has banned the celebration of Christmas and other seasonal celebrations.   

  • Myanmar saw 20 new cases on March 1, taking the total to 141,916 amid 3,199 deaths.
  • The country saw six new cases on February 28, taking the total to 141,896 amid 3,199 deaths.
  • Myanmar reported 15 new cases and one death on February 27, bringing the total to 141,890 and 3,199 deaths.
  • Myanmar saw 34 new cases on February 26, bringing the total to 141,875 amid 3,197 deaths.

Philippines

The Philippines aims to commence vaccinations from June 2021 and expects to inoculate about 25 million people (about 25 percent of its population) over the course of the year. The country has been badly affected by the virus and has the second-highest rate in Southeast Asia. The business community has reacted, more than 30 local companies signed an agreement to purchase at least 2.6 million vaccine doses from AstraZeneca in the country’s first such deal to secure coronavirus vaccines, ten days ago. They plan to donate a large part of the doses to the government for its planned vaccination program and use the rest to inoculate their employees. 

  • The Philippines recorded 2,037 new cases and four deaths on March 1, taking the totals to 578,381 cases and 12,322 deaths.
  • The Philippines reported 2,113 new cases and 29 deaths on February 28, bringing the tallies to 576,352 cases and 12,318 deaths.
  • The Philippines recorded 2,921 new cases and 42 deaths on February 27, taking the totals to 574,247 cases and 12,289 deaths.

Singapore

Singapore has been working on producing its own ‘Lunar’ vaccine, in a joint venture between the US company Arcturus together with the Duke-NUS medical school. It is a single dose, mRNA shot, developed from genetically engineering COVID-19 genes into an otherwise harmless virus. This technique is marginally safer than other vaccines which rely on dead Covid-19 material to provoke an immune response. The vaccine is expected to be available from Q1 2021. High-risk personnel will receive the vaccine first in a process to be determined by the government.     

  • Singapore reported 12 new cases on March 1, bringing the total to 59,948 amid 29 deaths.
  • The country reported 11 new cases on February 28, taking the total to 59,936 amid 29 deaths.
  • Singapore saw 12 new cases on February 27, bringing the total to 59,925 amid 29 deaths.

Thailand

Thailand is currently expecting vaccines to be delivered in mid-2021. The doses would cover 13 million people in a population of about 69 million. Thailand’s National Vaccine Institute signed a non-refundable advance market commitment contract worth 2.38 billion baht (US$79 million) with AstraZeneca to reserve the supplies. Discussions are also on-going with Oxford University in the UK to secure a vaccine that could be available in Q1 if trials are completed in time.   

  • Thailand recorded 80 new cases on March 1, taking the total to 26,031 amid 83 deaths.
  • Thailand reported 70 new cases on February 28, bringing the total to 25,951 amid 83 deaths.
  • Thailand saw 72 new cases on February 27, bringing the total to 25,881 amid 83 deaths.
  • The country saw 45 new cases on February 26, taking the total to 25,809 amid 83 deaths.

Vietnam

Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), a division of Vietnam’s Ministry of Health, has signed an agreement with Medigen Vaccine, a Taipei, Taiwan-based vaccine company to secure the supply of 3 million to 10 million COVID-19 vaccine doses in 2021. Medigen is currently conducting Phase II studies of the vaccine, co-developed with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam with a view to a Q1 2021 rollout.  

Vietnam is also working on producing its own vaccine, with the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang City, partnering with New York City-based Icahn School of Medicine and the global health non-profit organization PATH. Phase 1 trials are already underway in Vietnam, while Phases 2 & 3 will be conducted at the beginning of 2021. The institute plans to submit documents for approval to the health ministry as early as April next year and claims to be capable of producing 30 million doses a year, expecting that a national vaccine could be distributed to the general population in October 2021.

  • As of March 2, 2021, Vietnam’s Ministry of Health confirmed a total of 2,472 cases of COVID-19. However, 1,892 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 35 deaths due to the pandemic. The latest community transmission cases have been reported from Hai Duong.
  • As of March 1, 2021, Vietnam’s Ministry of Health confirmed a total of 2,448 cases of COVID-19. However, 1,876 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 35 deaths due to the pandemic. The latest community transmission cases have been reported from Hai Duong.
  • The country saw 16 new cases on February 28, taking the total to 2,448.
  • Vietnam reported six new cases on February 27, bringing the total to 2,432.

Other Asian countries and Regions

Afghanistan

Afghanistan faces two pandemics at the same time, Covid-19 and Polio. UNICEF is currently embarking on an urgent Polio vaccination program while the country is in talks with both China and Russia oversupplying COVID-19 vaccines. Government-imposed lockdowns increased conflict with the Taliban, and an overall lack of awareness of the disease has prevented many Afghani’s from obtaining treatment of either. 

  • As of March 1, Afghanistan has 55,759 cases and 2,446 deaths.
  • As of February 28, Afghanistan has 55,733 cases and 2,444 deaths.
  • Afghanistan has 55,714 cases and 2,443 deaths as of February 27.

Bangladesh

Bangladesh will receive 68 million doses of the COVID-19 vaccine from Gavi, which is committed to ensuring at least 20 percent of populations are inoculated. Each complete dose will cost about 200 Taka (US$2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5). Vaccinations are expected to commence in Q1 2021.     

  • As of March 1, Bangladesh has 546,801 cases and 8,416 deaths.
  • As of February 28, Bangladesh has 546,216 cases and 8,408 deaths.
  • Bangladesh has 545,831 cases and 8,400 deaths as of February 27.

Bahrain

Bahrain has begun COVID-19 vaccinations for front line personnel using a joint Chinese-UAE Sinopharm product. Roll out among the general population is expected in Q1 2021.  

  • Bahrain has 123,039 cases and 452 deaths as of March 1.
  • Bahrain has 122,394 cases and 449 deaths as of February 28.
  • Bahrain has 121,778 cases and 444 deaths as of February 27.

China

For specific updates concerning China, please click here.

For a complete overview of China’s vaccine availability please go here.

  • China saw 11 new cases on March 2, taking the total to 89,923.
  • China recorded 19 new cases on March 1, bringing the total to 89,912.
  • China reported six new cases on February 28, taking the total to 89,893.

East Timor

East Timor is receiving assistance from the Gavi Institute.  

  • East Timor has 113 cases as of February 26.
  • East Timor has 110 cases as of February 25.
  • As of February 24, East Timor has 109 cases.

Hong Kong

Hong Kong will provide COVID-19 vaccines free to all residents, with a vaccine being delivered in stages. The government has said it may take most of 2021 to reach 100 percent coverage for all citizens.  

  • Hong Kong has 11,020 cases and 200 deaths as of March 1.
  • Hong Kong has 11,006 cases and 199 deaths as of February 28.
  • Hong Kong has 10,984 cases and 198 deaths as of February 27.

India

For a complete overview of India’s vaccine availability please go here.

  • As of March 1, India has 11,122,229 cases and 157,250 deaths.
  • India has 11,112,012 cases and 157,193 deaths as of February 28
  • Our new India-specific updates can be found here.

Iran

Iran is jointly producing a COVID-19 vaccine with Russia, and the product has entered trials. National inoculation is expected to commence in September 2021.   

  • Iran has 1,639,679 cases and 60,181 deaths as of March 1.
  • Iran has 1,631,169 cases and 60,073 deaths as of February 28.
  • Iran has 1,623,159 cases and 59,980 deaths as of February 27.

Iraq

Iraq is currently in discussions with US company Pfizer concerning supplies of a COVID-19 vaccine. Supplies are expected in Q2 2021. 

  • As of March 1, Iraq has 699,088 cases and 13,428 deaths.
  • Iraq has 695,489 cases and 13,406 deaths as of February 28.
  • Iraq has 692,241 cases and 13,383 deaths as of February 27.

Japan

Japan is sourcing 145 million doses of vaccine from the United States and the UK and will be delivering them free of charge to all citizens commencing Q1 2021. 

  • Japan has 432,773 cases and 7,887 deaths as of March 1.
  • Japan has 431,740 cases and 7,860 deaths as of February 28.
  • Japan has 430,539 cases and 7,807 deaths as of February 27.

Jordan

Jordan is sourcing vaccines from Pfizer and expects to commence vaccinations from Q1 2021. 

  • As of March 1, Jordan has 397,158 cases and 4,727 deaths.
  • Jordan has 391,090 cases and 4,701 deaths as of February 28.
  • Jordan has 386,496 cases and 4,675 deaths as of February 27.

Kazakhstan

Kazakhstan has been developing its own vaccines with ‘Quazcovid’ being admitted by the WHO as a safe candidate. These are currently undergoing trials with a roll out expected in Q2 2021.  

  • Kazakhstan has 213,431 cases and 2,540 deaths as of March 1.
  • Kazakhstan has 212,809 cases and 2,540 deaths as of February 28.
  • Kazakhstan has 212,018 cases and 2,540 deaths as of February 27.

Kuwait

All citizens, including expatriates, will receive COVID-19 vaccines for free. Kuwait is importing one million vaccines from Pfizer, 1.7 million from Moderna, and three million doses of the Oxford-AstraZeneca vaccines and will commence a nationwide program from January.

  • As of March 1, Kuwait has 192,031 cases and 1,085 deaths.
  • Kuwait has 190,852 cases and 1,083 deaths as of February 28.
  • Kuwait has 189,890 cases and 1,078 deaths as of February 27.

Kyrgyzstan

Kyrgyzstan is sourcing vaccines from Russia with the Sputnik V vaccine expected to be rolled out in Q2 2021. 

  • Kyrgyzstan has 86,251 cases and 1,466 deaths as of March 1.
  • Kyrgyzstan has 86,229 cases and 1,464 deaths as of February 28.
  • Kyrgyzstan has 86,185 cases and 1,463 deaths as of February 27.

Lebanon

Lebanon is sourcing vaccines from Pfizer and is expected to take deliveries from mid-February 2021.  

  • As of March 1, Lebanon has 376,938 cases and 4,743 deaths.
  • Lebanon has 375,050 cases and 4,692 deaths as of February 28.
  • Lebanon has 372,792 cases and 4,652 deaths as of February 27.

Macao

Macao is part of the Covax scheme and is expected to receive 1.4 million doses of vaccine. The product will cost Pataca 300 (US$40). Roll out is expected in late Q1 2021.   

  • Macao has 48 cases as of February 5.
  • The number of cases has reached 45 as of July 24.
  • Macao records a single infection, bringing the total to 43.

Maldives

The Maldives will receive vaccines under the Covax program and will receive enough products to reach 20 percent of its population. Roll out is expected in Q2 2021.  

  • As of March 1, the Maldives has 19,979 cases and 62 deaths.
  • The Maldives has 19,793 cases and 62 deaths as of February 28.
  • The Maldives has 19,597 cases and 61 deaths as of February 27.

Mongolia

Mongolia is in discussions with Astra-Zeneca to purchase COVID-19 vaccines and is also part of the Covax scheme. Roll out is expected in Q2 2021. 

  • Mongolia has 2,952 cases and two deaths as of March 1.
  • Mongolia has 2,907 cases and two deaths as of February 28.
  • Mongolia has 2,866 cases and two deaths as of February 27.

Nepal

Nepal will source COVID-19 vaccines under the Covax program and will also purchase supplies from India. The rollout is expected from Q2 2021.  

  • Nepal has 274,216 cases and 2,777 deaths as of March 1.
  • Nepal has 274,143 cases and 2,774 deaths as of February 28.
  • Nepal has 274,065 cases and 2,773 deaths as of February 27.

North Korea

North Korea is expected to receive Covid-19 vaccines from China, with rumors that North Korean Leader Kim Jong-Un has already received treatment as part of medical trials.  

  • North Korea has reported its first case on July 25, the city of Kaesong is under lockdown.

Oman

Oman has sourced COVID-19 vaccines from Gavi and is buying additional supplies from Astra-Zeneca and Pfizer. Roll out will commence from January 2021 with each shot costing 10 Rial (US$24).    

  • Oman has 141,808 cases and 1,577 deaths as of March 1.
  • Oman has 141,496 cases and 1,570 deaths as of February 28.
  • Oman has 140,588 cases and 1,562 deaths as of February 25.

Pakistan

Pakistan is also suffering from a Polio epidemic and is struggling with dealing with both. However, it has stated it will provide the vaccine for free with national inoculations to start from April 2021. 

  • Pakistan has 581,365 cases and 12,896 deaths as of March 1.
  • Pakistan has 579,973 cases and 12,860 deaths as of February 28.
  • Pakistan has 578,797 cases and 12,837 deaths as of February 27.

Palestine

Israel is currently negotiating with the UAE to provide 1.5 million doses of vaccine to Palestine. The product is expected to be the Russian Sputnik V treatment and should be available to Palestinians in Q2 2021.   

  • As of March 1, Palestine has 185,336 cases and 2,058 deaths.
  • Palestine has 183,612 cases and 2,042 deaths as of February 28.
  • Palestine has 181,909 cases and 2,025 deaths as of February 27.

Qatar

Qatar has signed an agreement with Moderna to provide Covid-19 vaccines and has also signed deals with Pfizer and BioNTech. These will be made available from late Q1 2021. 

  • Qatar has 164,137 cases and 259 deaths as of March 1.
  • Qatar has 163,664 cases and 258 deaths as of February 28.
  • Qatar has 163,197 cases and 257 deaths as of February 27.

Russia

A complete overview of the availability and production of Russian Covid-19 vaccines and costs can be found here.

  • Russia has 4,257,650 cases and 86,455 deaths as of March 1.
  • Russia has 4,246,079 cases and 86,122 deaths as of February 28.
  • Our new Russia-specific updates here.

Saudi Arabia

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said last week that it had signed an agreement with the German biopharmaceutical company CureVac to provide Covid-19 vaccine. It plans to cover 70 percent of its population by the end of 2021 with treatment being available for free. The initial roll out is expected to be at the end of Q1 2021. 

  • Saudi Arabia has 377,700 cases and 6,500 deaths as of March 1.
  • Saudi Arabia has 377,383 cases and 6,494 deaths as of February 28.
  • Saudi Arabia has 377,061 cases and 6,488 deaths as of February 27.

South Korea

South Korea has reached a deal with AstraZeneca to purchase its coronavirus vaccine candidate and is in final talks with global drug-makers including AstraZeneca, Pfizer Inc, and Johnson & Johnson over their vaccines. It launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval. Roll out is expected in Q1 2021. 

  • As of March 2, South Korea has 90,372 cases and 1,606 deaths.
  • South Korea has 90,031 cases and 1,605 deaths as of March 1.
  • South Korea has 89,676 cases and 1,603 deaths as of February 28.

Sri Lanka

Sri Lanka is to receive 4.2 million doses of the COVID-19 vaccine from Gavi, enough to cover 20 percent of the population. It has not yet released information on when these will be made available.    

  • As of March 1, Sri Lanka has 83,552 cases and 476 deaths.
  • Sri Lanka has 83,094 cases and 464 deaths as of February 28.
  • Sri Lanka has 82,890 cases and 464 deaths as of February 27.

Taiwan

Taiwan has been developing its own vaccine and is also part of the Covax scheme. It has stated it will be able to manufacture enough of its own product for 50 percent population coverage with roll-out expected in Q1 2021.  

  • Taiwan has 955 cases as of February 28.
  • Taiwan has 951 cases and nine deaths as of February 25.
  • As of February 24, Taiwan has 946 cases and nine deaths.

Turkey

Turkey has purchased 50 million doses of China’s Cornavac, manufactured by Sinopharm. These will be made available for free to the most at-risk population, inoculations start on December 11. Other treatments will be purchased and made available via medical outlets during the year and sold at cost price, and are likely to include products from Pfizer and Russia.   

  • Turkey has 2,711,479 cases and 28,638 deaths as of March 1.
  • Turkey has 2,701,588 cases and 28,569 deaths as of February 28.
  • Turkey has 2,693,164 cases and 28,503 deaths as of February 27.

United Arab Emirates

The UAE is expected to authorize the use of China’s Sinopharm vaccine which is nearing the end of its clinical trials in the Emirates.  The UAE’s Prime Minister, Sheikh Mohammed bin Rashid Al Maktoum was inoculated as part of the testing. Roll out is expected in Q1 2021. The UAE is also manufacturing the vaccine and hopes to produce between 75-100 million doses during the year.  

  • As of March 1, the UAE has 394,050 cases and 1,238 deaths.
  • The UAE has 391,524 cases and 1,221 deaths as of February 28.
  • The UAE has 388,594 cases and 1,213 deaths as of February 27.

Uzbekistan

Uzbekistan has been trailing China’s Anhui Zhifei Longcom Biopharmaceutical vaccine in addition to vaccines made by China’s Sinopharm and Russia’s Sputnik V. Roll out is expected in Q1 2021. 

  • As of March 1, Uzbekistan has 79,926 cases and 622 deaths.
  • Uzbekistan has 79,886 cases and 622 deaths as of February 28.
  • Uzbekistan has 79,836 cases and 622 deaths as of February 27.

Yemen

Yemen is suffering from war and diseases such as diphtheria, while local politicians have made wild claims that the country will develop its own COVID-19 vaccine. It is a member of the Gavi program and relief is likely to come from humanitarian sources.   

  • As of March 1, Yemen has 2,310 cases and 634 deaths.
  • Yemen has 2,285 cases and 634 deaths as of February 28.
  • Yemen has 2,269 cases and 631 deaths as of February 27.

Related Reading


About Us

ASEAN Briefing is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia and maintains offices throughout ASEAN, including in SingaporeHanoiHo Chi Minh City, and Da Nang in Vietnam in addition to Batam and Jakarta, in Indonesia. We also have partner firms in Malaysia, Bangladesh, the Philippines, and Thailand as well as our practices in China and India. Please contact us at asia@dezshira.com or visit our website at www.dezshira.com.